NO996179L - Nye 1,2-ditiolanforbindelser, en fremgangsmÕte for deres fremstilling og farmasøytiske blandinger inneholdende disse - Google Patents

Nye 1,2-ditiolanforbindelser, en fremgangsmÕte for deres fremstilling og farmasøytiske blandinger inneholdende disse

Info

Publication number
NO996179L
NO996179L NO996179A NO996179A NO996179L NO 996179 L NO996179 L NO 996179L NO 996179 A NO996179 A NO 996179A NO 996179 A NO996179 A NO 996179A NO 996179 L NO996179 L NO 996179L
Authority
NO
Norway
Prior art keywords
new
preparation
pharmaceutical compositions
compositions containing
aralkyl
Prior art date
Application number
NO996179A
Other languages
English (en)
Norwegian (no)
Other versions
NO996179D0 (no
Inventor
Solo Goldstein
Claude Guillonneau
Yves Charton
Pierre Lestage
Brian Lockhart
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO996179D0 publication Critical patent/NO996179D0/no
Publication of NO996179L publication Critical patent/NO996179L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO996179A 1998-12-15 1999-12-14 Nye 1,2-ditiolanforbindelser, en fremgangsmÕte for deres fremstilling og farmasøytiske blandinger inneholdende disse NO996179L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9815821A FR2787109B1 (fr) 1998-12-15 1998-12-15 Nouveaux derives de 1,2-dithiolane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
NO996179D0 NO996179D0 (no) 1999-12-14
NO996179L true NO996179L (no) 2000-06-16

Family

ID=9533988

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996179A NO996179L (no) 1998-12-15 1999-12-14 Nye 1,2-ditiolanforbindelser, en fremgangsmÕte for deres fremstilling og farmasøytiske blandinger inneholdende disse

Country Status (22)

Country Link
US (1) US6150358A (xx)
EP (1) EP1010698B1 (xx)
JP (1) JP3256787B2 (xx)
KR (1) KR20000057059A (xx)
CN (1) CN1131226C (xx)
AT (1) ATE215080T1 (xx)
AU (1) AU756213B2 (xx)
BR (1) BR9908661A (xx)
CA (1) CA2292248C (xx)
DE (1) DE69901088D1 (xx)
DK (1) DK1010698T3 (xx)
EA (1) EA003424B1 (xx)
ES (1) ES2174582T3 (xx)
FR (1) FR2787109B1 (xx)
HK (1) HK1027348A1 (xx)
HU (1) HUP9904592A3 (xx)
NO (1) NO996179L (xx)
NZ (1) NZ501783A (xx)
PL (1) PL337172A1 (xx)
PT (1) PT1010698E (xx)
SI (1) SI1010698T1 (xx)
ZA (1) ZA997707B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413707B1 (en) 2000-12-29 2002-07-02 Eastman Kodak Company Photographic element with yellow dye-forming coupler and stabilizing compound having improved light stability
US7202270B2 (en) * 2003-06-20 2007-04-10 Sami Labs Limited Convenient stable non-hygroscopic crystalline solid forms of racemic and chiral LA-plus salts: process for their manufacture and uses
JP2010520333A (ja) * 2007-03-01 2010-06-10 セダーズ−シナイ メディカル センター 〔１，２〕−ジチオラン部分を含有する抗酸化剤重合体およびその使用
US9028874B2 (en) * 2008-01-03 2015-05-12 Cedars-Sinai Medical Center Antioxidant nanosphere comprising [1,2]-dithiolane moieties
US8603531B2 (en) 2008-06-02 2013-12-10 Cedars-Sinai Medical Center Nanometer-sized prodrugs of NSAIDs
ES2529060T3 (es) 2008-11-24 2015-02-16 Cedars-Sinai Medical Center Derivados antioxidantes de la camptotecina y nanoesferas antineoplásicas antioxidantes de los mismos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU586174A1 (ru) * 1976-04-26 1977-12-30 Уфимский Нефтяной Институт Способ получени 1,3-дитиациклоалканов
US4178291A (en) * 1976-12-03 1979-12-11 E. R. Squibb & Sons, Inc. Substituted acyl derivatives of amino acids
CH656382A5 (de) * 1983-10-24 1986-06-30 Sandoz Ag Sulfoxide, verfahren zu ihrer herstellung und ihre verwendung.
FR2707983A1 (fr) * 1993-07-21 1995-01-27 Pf Medicament Nouveaux dérivés de l'acide lipoïque et dihydrolipoïque, leur préparation et leur application en thérapeutique humaine.
CZ96798A3 (cs) * 1997-04-02 1998-10-14 Sankyo Company Limited Deriváty dithiolanu, jejich příprava a jejich terapeutické účinky

Also Published As

Publication number Publication date
ES2174582T3 (es) 2002-11-01
EA199901034A3 (ru) 2000-10-30
JP2000178270A (ja) 2000-06-27
DE69901088D1 (de) 2002-05-02
US6150358A (en) 2000-11-21
JP3256787B2 (ja) 2002-02-12
CN1257072A (zh) 2000-06-21
NO996179D0 (no) 1999-12-14
SI1010698T1 (en) 2002-06-30
HUP9904592A3 (en) 2001-09-28
CN1131226C (zh) 2003-12-17
BR9908661A (pt) 2000-10-17
NZ501783A (en) 2000-09-29
EP1010698A1 (fr) 2000-06-21
FR2787109B1 (fr) 2001-01-19
CA2292248C (fr) 2004-04-13
ZA997707B (en) 2000-06-27
CA2292248A1 (fr) 2000-06-15
EA003424B1 (ru) 2003-04-24
FR2787109A1 (fr) 2000-06-16
HUP9904592A2 (hu) 2001-04-28
EA199901034A1 (ru) 2000-10-30
PL337172A1 (en) 2000-06-19
HK1027348A1 (en) 2001-01-12
HU9904592D0 (en) 2000-02-28
DK1010698T3 (da) 2002-07-22
AU6523899A (en) 2000-06-22
AU756213B2 (en) 2003-01-09
ATE215080T1 (de) 2002-04-15
PT1010698E (pt) 2002-07-31
KR20000057059A (ko) 2000-09-15
EP1010698B1 (fr) 2002-03-27

Similar Documents

Publication Publication Date Title
DK165370C (da) Benzoxazol-, benzothiazol- og thiazolopyridinaminderivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse
IS8843A (is) Hálfmálmaprótínasa hindra mót
NO930768L (no) Substituerte aminofosfonatderivater, fremgangsmaate for deres fremstilling og farmasoeytiske preparater derav
ATE279411T1 (de) Fluorszierende marker
DK1026170T3 (da) Erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
DE68926981D1 (de) Cephemverbindungen und Verfahren zu ihrer Herstellung
NO923282D0 (no) 1,7-kondenserte 2-(piperazinoalkyl)-indolderivater, saavelsom fremgangsmaater og mellomprodukter for fremstilling avdisse, og legemidler inneholdende disse
NO996179D0 (no) Nye 1,2-ditiolanforbindelser, en fremgangsmåte for deres fremstilling og farmasoeytiske blandinger inneholdende disse
NZ230934A (en) Aromatic group-containing derivatives of piperazine, preparation thereof and pharmaceutical compositions
NO972943D0 (no) 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende disse forbindelsene og deres anvendelse
AU1735397A (en) Pyridonecarboxylic acid derivatives and intermediates for the synthesis thereo
IL67464A0 (en) N,n-disubstituted alkenamides and phenylalkenamides,their production and pharmaceutical compositions containing them
NO972942D0 (no) 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende disse forbindelsene og deres anvendelse
NO903084D0 (no) Farmasoeytisk anvendbare thiazol-derivater og fremgangsmaate for deres fremstilling.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application